The Clorox Company (NYSE:CLX) Shares Sold by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC trimmed its position in The Clorox Company (NYSE:CLXFree Report) by 35.3% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 213,141 shares of the company’s stock after selling 116,130 shares during the period. Allspring Global Investments Holdings LLC owned about 0.17% of Clorox worth $32,634,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. CIBC Private Wealth Group LLC boosted its position in Clorox by 0.5% during the fourth quarter. CIBC Private Wealth Group LLC now owns 13,900 shares of the company’s stock worth $1,982,000 after acquiring an additional 66 shares during the last quarter. First National Bank of Mount Dora Trust Investment Services grew its position in shares of Clorox by 3.2% in the fourth quarter. First National Bank of Mount Dora Trust Investment Services now owns 2,257 shares of the company’s stock valued at $322,000 after purchasing an additional 71 shares during the period. Modera Wealth Management LLC grew its position in shares of Clorox by 1.4% in the third quarter. Modera Wealth Management LLC now owns 5,130 shares of the company’s stock valued at $672,000 after purchasing an additional 71 shares during the period. Czech National Bank increased its stake in Clorox by 0.3% in the fourth quarter. Czech National Bank now owns 21,718 shares of the company’s stock valued at $3,097,000 after purchasing an additional 71 shares during the last quarter. Finally, Global Retirement Partners LLC lifted its position in Clorox by 7.2% during the fourth quarter. Global Retirement Partners LLC now owns 1,089 shares of the company’s stock worth $156,000 after buying an additional 73 shares during the period. 78.53% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the stock. BNP Paribas assumed coverage on shares of Clorox in a research note on Monday, June 24th. They set an “underperform” rating and a $130.00 price objective for the company. Jefferies Financial Group raised shares of Clorox from an “underperform” rating to a “hold” rating and set a $145.00 price target on the stock in a research note on Tuesday, March 26th. Deutsche Bank Aktiengesellschaft lowered their price objective on shares of Clorox from $155.00 to $151.00 and set a “hold” rating for the company in a research note on Wednesday, April 17th. DA Davidson reiterated a “neutral” rating and issued a $162.00 target price on shares of Clorox in a report on Wednesday, April 17th. Finally, Morgan Stanley reissued an “equal weight” rating and set a $160.00 price target on shares of Clorox in a research report on Tuesday, March 26th. Five research analysts have rated the stock with a sell rating and fourteen have given a hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $145.33.

Check Out Our Latest Report on Clorox

Clorox Stock Performance

NYSE:CLX opened at $132.46 on Friday. The firm has a 50-day moving average of $136.18 and a two-hundred day moving average of $143.59. The company has a debt-to-equity ratio of 9.73, a current ratio of 0.90 and a quick ratio of 0.53. The stock has a market cap of $16.45 billion, a P/E ratio of 68.63, a PEG ratio of 1.98 and a beta of 0.39. The Clorox Company has a 1-year low of $114.68 and a 1-year high of $169.14.

Clorox (NYSE:CLXGet Free Report) last issued its quarterly earnings results on Tuesday, April 30th. The company reported $1.71 EPS for the quarter, beating analysts’ consensus estimates of $1.33 by $0.38. Clorox had a return on equity of 302.49% and a net margin of 3.33%. The firm had revenue of $1.81 billion during the quarter, compared to the consensus estimate of $1.87 billion. During the same quarter in the prior year, the business posted $1.51 earnings per share. Clorox’s revenue for the quarter was down 5.3% on a year-over-year basis. On average, research analysts expect that The Clorox Company will post 5.91 earnings per share for the current fiscal year.

About Clorox

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Articles

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.